The Kable

Home
Friday Kable
Features
About

Sitemap - 2022 - The Kable

πŸ’‰ Lilly widens RNA editing pact; Merck targets cancer; Merck too targets cancer

πŸ’Š Ready for the next pandemic? Nope; AstraZeneca to make novel drugs in the UAE

πŸ’Š Indian drugs under the scanner in Nepal; Treating depression with chatbots

πŸ’Š Sanofi re-ups partnership with Innate, Boehringer re-ups tie-up with Click; AbbVie says hello to depression

πŸ’Š Sosei continues Big Pharma alliances; WTO continues deferring decisions; China continues Covid transition

πŸ’‰ Lilly making insulin cheap in Africa; India says Maiden Pharma blameless

πŸ’Š Novartis joins rare cancer trial; Paxlovid gets $2B more from the US; Malaysia gets a hexavalent vaccine

πŸ’Š Takeda splurges billions on psoriasis; Moderna+Merck share positive news from cancer trial

πŸ’Š Amgen bets really, really big on rare diseases; Aspen gets fresh funding to make in Africa

πŸ’Š Gilead takes a shot at multiple myeloma; The WHO takes AMR advice to an app; Drug trials on lab cells in India soon

πŸ’‰ The WHO says AMR is on the rise; Serum Institute says an Ebola vaccine is on the way

πŸ’Š Aster DM goes to Iraq; Sun Pharma goes nowhere; Bull sperm goes missing

πŸ’Š Pfizer keeps on expanding; Glenmark gets more US FDA love; PEPFAR wants to scale African manufacturing

πŸ’Š Sanofi goes big down under; PAHO launches an AI assistant for alcoholism

πŸ’Š Pfizer goes big(ger) in Europe; Mpox no longer an emergency; Is that a Covid wave on the horizon?

πŸ’‰ Pfizer sets up a new biotech; Africa gets mpox vaccines; ViiV partners with Uber to end HIV

πŸ’Š AstraZeneca wins at Reuters Pharma Awards; Big Tech and the pharma landscape

πŸ’Š New hope for CCHF; Boston Scientific gets into gastro; Is Fosun selling Gland?

πŸ’Š AstraZeneca doubles down on cell therapy and respiratory ailments; Monkeypox gets a new name, sort of

πŸ’Š CEPI bets on next-gen molecular clamps; Living long in Australia

πŸ’‰ Lupin gets more love from the US FDA; GARDP tacks on two new antibiotic discovery pacts

πŸ’Š Novartis looks to (maybe) fire millions of mosquitoes; The age of measles

πŸ’Š Novavax exits Gavi deal; Telangana’s Pharma City builds on farmer lands; Have you had your tea yet?

πŸ’Š One Merck buys a new cancer drug; The other Merck makes a big R&D play; Novo Nordisk ups its API game

πŸ’Š The climate summit for implementation fails to implement much; A Kable look at the Brazil pharma story

πŸ’‰ Gates Foundation pledges $7b for Africa; The WHO says the world’s teeth are in terrible shape

πŸ’Š Big Pharma not doing enough for access to drugs says new report; Novartis looking to offload ophthalmology and respiratory units

πŸ’Š Amazon’s virtual clinic takes off; Boomtime for biosimilars; GSK’s new TB treatment

πŸ’Š AstraZeneca looks to make healthcare in Egypt green; Thailand and Japan clear trials for Covid vaccines

πŸ’Š BioNTech buys Novartis plant in Singapore; Moderna looks to discover antibodies

πŸ’‰ New net-zero standards outlined; An AI tool for eye diseases; AstraZeneca’s cancer platform for Africa

πŸ’Š WHO says the global vaccine market is growing; PATH has a list of over 100 African healthtech ventures for you to partner with

πŸ’Š Sanofi’s new AI drug discovery pact; Pfizer seeks real-world insights; Gates Foundation looks to help farmers

πŸ’Š BioNTech plans a blockbuster 2023; Measuring the carbon footprint of digital Tx

πŸ’Š Obesity drug helps with weight loss; Climate change worse than cancer

πŸ’‰ Pfizer+BioNTech combine on a combination vaccine; Moderna has to defend itself

πŸ’Š Tired? Have a protein war; Sad? Have mushroom; RSV? Get a vaccine

πŸ’Š J&J buys a new piece of a heart; Indonesia goes big on health transformation

πŸ’Š GSK drug meets a ban in China; A new malaria antibody works

πŸ’Š Covid is over. Has anyone told Covid?

πŸ’‰ Nearly 11 million TB cases in 2021, says the WHO; T cells for anti-fungal vaccines

πŸ’Š Sanofi goes virtual for vaccine making; Moderna may make Ebola vaccines

πŸ’Š GSK trims its cell therapy pipeline; The Pan-Gulf CDC is launched; CEPI ties up with SK bio

πŸ’Š Measles-rubella vaccine now manufactured in Senegal; Industry bodies promise equal vaccine access in the future

πŸ’Š Merck β€œfinds” an Ebola vaccine; Lupin finds an FDA notice

πŸ’‰ Novartis licenses a cancer drug to MPP; Gates Foundation researchers a contraceptive with Bayer

πŸ’Š Merck licenses TB drugs to the Gates Foundation; Merck under fire in France; New cholera dosages

πŸ’Š Lilly digs deeper into gene therapy, LG Chem takes oncology to the US; Gilead bets on bispecific antibodies

πŸ’Š Moderna scraps Covax contract, signs new one; Serum’s making shots for Ebola

πŸ’Š Takeda’s dengue vaccine goes to Europe; Gates Foundation goes anti-polio

πŸ’‰ GSK’s RSV vaccine hits main goal in trials; Novartis hits a brick wall in court; Sanofi says sayonara to Japanese manufacturing

πŸ’Š A new vaccine trial for Ebola to get underway soon; AI goes deep into your prostate; GSK exits Kenya

πŸ’Š Merck to develop cancer vaccine with Moderna; Healthcare goes Meta; The AMA gets a new signature

πŸ’Š Panacea Biotech to supply pentavalent vaccines through UNICEF & PAHO; AstraZeneca’s nasal Covid vaccine flops in trials

πŸ’Š Bayer says Marhaba to Egypt; The HHS puts in $110-mn for Sudan ebolavirus

πŸ’‰ CEPI funds development of a nasal Betacoronavirus vaccine; BioNTech sets up a research facility in Australia

πŸ’Š Indian-made cough syrups under WHO scrutiny; Global Fund falls short of target; More than drugs needed for diabetes

πŸ’Š Google’s newest healthcare offering sees inside you; The WHO says dementia care needs priority

πŸ’Š Shionigi licenses its Covid antiviral to MPP; GMO makes a comeback in Kenya

πŸ’Š Moderna unlikely to make it in China; Chicken unlikely to make it in France, Bavarian Nordic sells directly to (some) Latam nation

πŸ’‰ Novo Nordisk moves further away from diabetes; The WHO says end all mosquitoes

πŸ’Š J&J’s consumer biz gets a name, Kenvue; Pfizer gets money from the Gates Foundation for vaccine development

πŸ’Š Sanofi bets on NK cells for cancer; Roche bets on solid tumours; Seagen bets on cancer too

πŸ’Š GSK breaks the glass ceiling again; Cuba gets a big biopharma boost

πŸ’Š The Global Fund rebounds with Pfizer’s Paxlovid; Japan gets ready for the next pandemic.

πŸ’‰ Novartis’ goes America First; NASA wants to make an asteroid burst

πŸ’Š Flipkart’s e-pharmacy goes live in India; GSK wants to go green everywhere

πŸ’Š One digital health network for Africa; Water for everybody; Healthcare invests $400 million into Pharmaceuticals in Bangladesh

πŸ’Š South Sudan gets a regulatory framework; Nigeria’s Remedial seeks to cross borders

πŸ’Š Facebook makes depression worse; Patent abuse rigs up drug prices in the US

πŸ’‰ The Lancet skewers the WHO; Politico skewers Gavi, CEPI and others

πŸ’Š Making CAR-T inside the body; The WHO says the pandemic is ready to end; Pfizer's new flu shot in trials

πŸ’Š A new investigational antimalarial; Serum ties up with Nigeria; The US declares a polio emergency

πŸ’Š Novo Nordisk and Microsoft in a new partnership; Novartis pumps in millions into biologics

πŸ’Š Verily bets $1 billion on precision medicine; Dolo didn't dole donations

πŸ’‰ Covid is dead; long live Covid; Panacea and Glenmark get regulatory censure, Lupin gets a nod

πŸ’Š Dr Reddy's and Cipla launching BMS' cancer generics in the US; Africa building a whole lot of drug manufacturing units

πŸ’Š GSK's malaria vaccine gets the WHO nod; MSF calls for refocusing attention on HIV and TB

πŸ’Š Brazil's first bio CDMO in the works; Amazon's second healthcare buy fails

πŸ’Š Zydus and Lupin issue fresh recalls in the US; Polio, polio everywhere

πŸ’‰ Bivalent boosters barely better, believe boffins; Novo Nordisk and an acquisition 4 years in the making

πŸ’Š Aspen-SII in a vaccine deal for Africa; The US FDA loses in court

πŸ’Š GSK gets $170 million for the malaria vaccine; Flipkart to rain meds from the sky; South Africa bans travel for cows

πŸ’Š Churches cause contagion in Zimbabwe; A nasal Covid vaccine on the anvil; Enzymes to eat up all the plastic

πŸ’Š A new biolab in Nigeria; AI-based home visits in Rwanda; Libya gets mobile clinics

πŸ’Š Bangladesh wants a TRIPS waiver till 2033; UAE boosts Senegal’s health infra

πŸ’Š Merck boosts its neuroscience pipeline; People in Brazil have had it with monkeys

πŸ’Š Cuba to make antibiotics locally; Africa gets a new fund for community health workers

πŸ’Š Pfizer buys Global Blood; ByteDance buys a hospital in China; Taiwan urges vaccination for shingles

πŸ’‰ Sanofi looks to China; Gilead bets on immune checkpoints; Amgen punts $4 billion on autoimmune therapies

πŸ’Š Roche bets $6 billion on CAR-T; Guatemala gets monkeypox too

πŸ’Š 2 to 3 Omanis flying overseas for treatment daily; Nigeria’s UHC plan gets WHO backing

πŸ’Š A new partnership to make TB drugs cheaper; World Bank says food is getting dearer; Brazil gets a monkeypox drug

πŸ’Š Indian-approved drugs not effective says a study; Bangladesh to send drugs to Uzbekistan

πŸ’‰ Generic AIDS injections for everyone; The protein universe unveiled; Science says spend time with yourself

πŸ’Š AIDS on the rise again; Wuhan in lockdown again; Covid takes over Tokyo again

πŸ’Š BiogΓ©nesis Bagó’s new Korean unit; BioNTech+Pfizer respond to CureVac; 70% of India’s medical devices imported

πŸ’Š Sanofi out-licenses siRNA platform; A new malaria vector found; Monkeypox goes viral

πŸ’Š Monkeypox is finally declared an emergency; Ecuador moots a menstrual permit

πŸ’‰ Coming soon: Amazon Prime Healthcare; Covid is dead, long live Covid; New bugs to kill superbugs

πŸ’Š Valneva’s vaccine vagaries; AbbVie’s optical investment; Junk DNA gives you cancer

πŸ’Š Roche bets a billion on eye treatments; AfDB pumps in $1.5 billion for food security

πŸ’Š Africa CDC gets more teeth; Bangladesh rolls out a vaccine; Brazil goes psychedelic

πŸ’Š Merck woos Asian startups; Marburg virus confirmed in Ghana; Pfizer sues Amgen

πŸ’‰ Bayer offloads testosterone; Drugs shortage in Malaysia; Royalty Pharma buys a pharma royalty

πŸ’Š Another day, another lawsuit; Monkeypox may have landed in India; Merck partners with Orion on prostate cancer

πŸ’Š Sanofi on a selling spree, The WHO talks AMR and genomics; Amazon’s cancer vaccine

πŸ’Š Aspen to market Tamiflu; Vertex buys out a diabetes rival; Moderna trials a Nipah vaccine

πŸ’Š Afrigen ties up with the US NIH; Sinopharm to buy BBI; Save your gut microbiome

πŸ’‰ Malaysian influencers replace doctors; McKinsey tells the Middle East to go digital; World Bank gives IDA $93 billion

πŸ’Š Merck to buy Seagen; Cuba to build a vaccine plant in Nigeria; Medicine in Medellin

πŸ’Š Sanofi works on RNA expression; Lilly backs CRO funding; Mitsubishi gets into gene editing

πŸ’Š Sanofi’s new Impact; CEPI’s new partnership; Africa’s new zoonotic disease coordination group

πŸ’Š A new pain-relieving implant; Lotte sets up shop in the US; Superbugs on the rise in Bangladesh

πŸ’‰ Pfizer ties up with Sirana; Novartis opens a new manufacturing unit; And Covid is over… NOT!

πŸ’Š India gets an mRNA vaccine; Merck wants to accelerate healthcare; Amgen makes a sale in Turkey

πŸ’Š Pfizer’s new biotech baby; Novartis says 8000 bye-byes; Astella says hi to Sutro

πŸ’Š Ipsen buys Epizyme; Cipla invests in GoApptiv; Sanofi partners with Health2Sync

πŸ’Š Saudi to make drugs locally; UAE ties up with J&J; Monkeypox not an emergency

πŸ’Š Africa secures $4 billion for neglected diseases, GSK, Eisai, Gates Foundation join Novartis with pledges

πŸ’Š Another Covid patent lawsuit for Pfizer; Novartis pledges $250 million into NTD

πŸ’Š Novartis’ new gene-editing pact; Gavi’s new vaccine partnership; Drug-resistant typhoid

πŸ’Š Biocon Biologics beats back bribery barbs; Afrigen makes a Covid vaccine; Japan gets its own CDC

πŸ’Š Pfizer buys into Valneva; Boehringer wants to rid dogs of cancer; Nobody wants a TRIPS deal anymore.

πŸ’‰ Abu Dhabi signs up with J&J too; WHO says Africa CDC good; Researchers find the source of chronic pain

πŸ’Š Weekend testing for everyone in Shanghai till July; Abu Dhabi partners with Sanofi; MorphoSys moves to oncology

πŸ’Š A new name for monkeypox; Spies in Venezuelan hospitals; Dead penguins in New Zealand

πŸ’Š Karkinos has a new central lab; ADQ acquires BMG; The state of biotech 2022

πŸ’Š AI comes alive; Pfizer teaches Indian nurses about AMR; Sanofi says its Covid vax is a good booster

πŸ’Š Reliance makes $8 bn bid for Boots; BioNTech to start Rwanda construction soon

πŸ’‰ Amul loves plastic straws; BMS taps AI for clinical trials; Sanofi launches a new accelerator

πŸ’Š Africa gets a full-service vaccine plant; A robot surgeon gets money; Pristyn Care acquires Lybrate

πŸ’Š Novartis gets hacked; Yumanity says bye-bye; Bahrain says shalom to Israel

πŸ’Š BMS buys cancer drugs; No sex for hornbills; Kiwis go to jail

πŸ’‰ Lupin recruits from the US FDA; Novartis to build capability in KSA; Regeneron pays Sanofi to break up; The Kable celebrates #100

πŸ’Š Roche buys a cancer drug; Astellas Goes into glycoproteomics; Median Tech gets into AI imaging

πŸ’Š Pfizer no longer interested in Haleon; AI to treat hair; $600 million for cheaper genomics

πŸ’Š GSK’s big vaccine bet; The WHO says tobacco bad; The UK says sex bad; A Finnish startup says bones good

πŸ’Š ViiV wants to make HIV meds available to all; Revital launches a new respirator

πŸ’‰ Torrent buys drugs from Dr Reddy’s; Medtronic’s new kidney play; FullLife gets money to delve into half-life

πŸ’Š Germany says ja to Covaxin; Cancer killing viral vaccine goes into trial; Eli Lilly spends $2 billion on expanding home ops

πŸ’Š Pfizer and Bayer get busy giving; India wants the world to reduce sugar intake; Australia does Australia things

πŸ’Š Chemo Pharma goes to India; SII goes to Africa; Monkeypox goes everywhere

πŸ’Š Sun Pharma issues antidepressant recall; Egypt prepares for Doxx-ing; Are you up for some Air Protein?

πŸ’‰ Pfizer digs in on digital; Lilly votes for AI; Dr Reddy’s says privyet to Russia

πŸ’Š Adani Healthcare goes live; The WHO pats itself on the back; Hengrui wants to make medicine affordable again.

πŸ’Š Warren Buffett breaks up with pharma; Mankind wants doctors to stream more; Pollution kills

πŸ’Š GSK becomes, well, GSK; Otsuka says sayonara to Akebia; GII buys into Almeswak

πŸ’Š Pfizer and BioNTech amend a vaccine deal, Valneva’s vaccine deal stumbles

πŸ’‰ BMS hands BridgeBio a lifeline; KPMG unveils a presentation; GE bets on ultrasound

πŸ’Š Novo Nordisk partners with Flagship; Nuvig comes out of stealth; Novavax and Moderna get ready to jab Thai kids

πŸ’Š Now Gavi says no to Aspen; Myanmar rolls out a Covid vaccine; Moderna links Kenya plant to demand

πŸ’Š Pfizer doesn’t want a tiny Biohaven stake anymore; Moma rakes in mo money; CEPI funds a variant-proof vaccine

πŸ’Š Expect more pharma entrepreneurs from India; Thailand gets a home-grown vaccine; Sanofi’s EUROAPI emerges into public view

πŸ’‰ Sanofi’s new CSR wing; Novartis stops cancer drug production; India seeks more data on a TB vaccine

πŸ’Š The sheen wears off of Paxlovid; Aurobindo and Zydus take cancer generics to the US; Pfizer sets up a research centre in India

πŸ’ŠMeta makes a mental health bet in Asia; China Mobile becomes a doctor in Hong Kong; The WHO says Europe needs to exercise

πŸ’Š Gilead’s $300 million oncology bet; The US FDA says no to China trials again; Birds check in to hospitals in India

πŸ’Š Adani plans a healthcare foray; Merck plans a Chinese expansion; Nigeria and Cuba in tech transfer partnership

πŸ’‰ India asks Bharat Biotech to shape up; Moderna asks the US FDA to sign off

πŸ’Š Molecular running out of partners; Reliance wants some big Boots; Kinder joy no more

πŸ’Š Novartis saying goodbye to 1000s while spending billions; Lupin goes to China with kiddie formulations; Ubie launches an β€œAI-based symptom checker”

πŸ’Š GOQii plans an English expedition; Ghana gets a new pharma plant; GSK launches a new inhaler

πŸ’Š Aurobindo, Sun, Jubilant recall drugs in the US; Paxlovid goes to India; SII stops vaccine production

πŸ’‰ Pfizer gets a pat on the back from the WHO; The WHO gets a thumbs down from Indonesia

πŸ’Š Sanofi breaks ground in Singapore; AbbVie breaks off a partnership; GSK faces a strike in the UK

πŸ’Š UAE’s Julphar goes big; Navidea goes to India; Mystery hepatitis goes to Israel

πŸ’Š Lupin gets an FDA nod, and an FDA rebuke; Bharat Biotech plans a Mexican sojourn

πŸ’Š Prime Healthcare to make halal pharmaceuticals; Fujifilm to make endoscopy tools for the US Army.

πŸ’‰ India seeks tech partners for its digital health network; Thailand gets American pot; US zoos can’t protect their birds

πŸ’Š Bharat Biotech held up by the US FDA; Altibbi ties up with Egypt again; AI keeps taking all the money

πŸ’Š Novartis prepping job cuts worldwide; Kinder Joy brings salmonella across the Atlantic.

πŸ’Š Pfizer buys an app to check your cough; Google gets closer to your heart

πŸ’Š Cadila launches a new rabies vaccine; Glenmark to run trials for a cancer molecule

πŸ’‰ Pfizer to reduce field staff in India; Lupin launches a contraceptive drug in the US

πŸ’Š Novartis breast cancer drug gets additional clearance; Sanofi bids farewell to Kadmon, NY; Retro Bio wants you to live loooonger

πŸ’Š J&J’s vax gets an upgrade; Pfizer wants to INDovate; Moderna’s massive charity giving

πŸ’Š Novartis restructures; Do you know more than a billion people? If not, you’re definitely breathing unhealthy air

πŸ’Š Bayer’s $1.4 billion Leap; Dr Reddy’s and German cannabis; Bharat Biotech to upgrade plants

πŸ’‰ A rebrand for Sanofi Bangladesh; Biological E gets an mRNA license; Zydus’ Covid vax 66% effective

πŸ’Š Fresenius makes a couple of acquisitions; the WHO plans to end the pandemic; KeyPlants ships a vaccine facility to Senegal

πŸ’Š A billion digital health users in India by 2030; GOQii wants to make a health metaverse; Alembic takes Aleor Dermaceuticals

πŸ’Š No TRIPS waiver for Covid vaccines? Altibbi gets money for an e-pharmacy

πŸ’Š A new TB vax for India? Maybe. A new lockdown in China? Depends on whom you ask

πŸ’‰ Sun Pharma $485 million lighter; South Korea’s big donation to Jamaica; OK Google book my doctor

πŸ’Š The WHO says Covid cases on the rise again; A mental health pandemic in South Africa

πŸ’Š Eat keto, treat cancer. Novavax okayed for Indian teens. Pharma makers defer strike in Pakistan

πŸ’Š Alembic and Glenmark get FDA nods; Hetero to make Sputnik Light; Expedia really wants Germans to take a break

πŸ’Š A new week; a new epidemic act for India; a new Covid drug; a new cannabis hub

πŸ’‰ 19 Indian companies sign up to make Pfizer drug; Covid on the rise again; All quiet on the Israel front

πŸ’Š A headset that can sense your thoughts; A water crisis in Pakistan; A new roadmap for TB in Kenya

πŸ’Š SII approaches regulators to jab 12-year-olds with Covovax; Cambodia gets a taste of Chinese tradition

πŸ’Š India goes all-in on medical tourism; 12- to 14-year olds in India prepare to get vaxxed.

πŸ’Š New policy for medical devices in India; New tactille Braille displays from Korea; China’s Covid struggles

πŸ’‰ 2 years of the pandemic; the WHO tells Ukraine to destroy pathogens; Singapore creates virtual wards

πŸ’Š India working on Omicron vaccines; Indian hospitals unhappy; Smoking causes Covid

πŸ’Š Boosters needed, says the WHO; Colleges needed, says an Indian court; Don’t eat me, says an octopus probably

πŸ’Š India’s Natco Pharma haΘ™ a cancer generic; Sri Lanka looks to increase drug prices; Kenya gets a vaccine factory

πŸ’Š A new malaria vaccine recommendation; India’s elderly get attention; Brazil’s home-grown vaccine

πŸ’‰ India gets a new Covid drug; South Korea and Vietnam set new records; Vaccination works

πŸ’Š Drugs get costlier in India; J&J launches allergy-fighting lens; HBR overstates our importance to robots

πŸ’Š India’s elderly bear the brunt of the pandemic; Weed is legal in Costa Rica; Recession causes physical pain; Nerve damage with long Covid

πŸ’Š A new month, A new Kable; Mankind continues to buy; Moderna gets hit with a lawsuit

Welcome back to The Kable. Biocon breaks out the big bucks; Biohaven expands and expands; Staying Covid-negative in Hong Kong.

πŸ’‰ India wants more health entrepreneurs; Plant-based vaccines in Canada; Indian pharma apprehensive about Ukraine

πŸ’Š Moderna continues to expand; Sanofi-GSK get into the Covid-19 vaccine game; Healthcare unicorns aplenty

πŸ’Š Is BA.2 worse? Some say yes. Others say no; Moderna enters the RSV queue; the US FDA gets busy

πŸ’ŠCEPI’s vaccine fund invests in India; Bayer to treat European kidneys; India says teenagers can get Corbevax; Pakistan’s first insulin patch

πŸ’Š Bharat Biotech goes to the US; Dr. Reddy’s goes to Russia; Moderna to the news; Covid is not actually mild in kids

πŸ’‰ Omicron is mild. Is it though? Kids in the UK and Australia to get vaccinated. Yumanity crashes and burns [Dad level pun we know]

πŸ’Š mRNA money spreads wings around the world; Biogen worries multiply; What about long Covid?

πŸ’Š Time to say goodbye to Covid? Not so fast; Wheeling and dealing aplenty in life sciences; Might Paxlovid be the silver bullet we need?

πŸ’Š The history of TB; Tracking wastewater; Shining the light on mental health

Pfizer’s Covid-19 vaccine not likely for young kids soon. Health care professionals are ending their own lives. Elon Musk managed to cause distress to monkeys. Vaccine production in Africa continues to see roadblocks

πŸ’‰CRISPR on the move, FDA on the move too, Novavax moves but doesn’t supply, drug companies are competing to scratch an itch

πŸ’Š WHO says Covid is still with us; BioNTech unhappy with the WHO’s Africa plans; New knees that can think

πŸ’Š J&J halts Covid-19 vaccine production, Pfizer predicts another bumper year, Deloitte expands, BioSplice contracts, #HKhamsters report from the ether

πŸ’ŠVaccines made, sold, tested; Wealth creation with CRAMs; Wuxi stock goes whoosh; Meet the new pacemaker in town

πŸ’Š UK’s NICE approves a $3 billion treatment; More bad news for Biogen; Cipla acquires more green energy stakes; Is Sanofi’s $11 billion bet beginning to pay off?

πŸ’‰ Sanofi rebrands; New drugs for Covid; Fake vaccines in India; Lawsuits galore; Ending malaria in Africa

πŸ’Š A cure for cancer; No sops to doctors; The HIV vaccine takes flight; BA.2 no worse than Omicron; Cuba, the vaccine powerhouse

πŸ’Š Musings from India’s Union budget; A good day for AI; The rise of gonorrhoea; Settlements, acquisitions, and deals, deals, deals.

πŸ’Š US FDA approvals galore; An end for many partnerships; Thinking about India’s Union budget

πŸ’Š The luck of the Irish, how many vaccine stocks are too many and how many Covid infections are too many

Β© 2024 The Kable
Privacy βˆ™ Terms βˆ™ Collection notice
Start WritingGet the app
Substack is the home for great culture